Katharine E. Spink, SVP Prgm Management, Cell Therapies at GERON CORP (GERN), sold 419 shares at $4.47 ($2K) on 2011-05-24, disclosed to the SEC on 2011-05-24.
Open-market sale of $2k GERN by SVP Prgm Management, Cell Therapies. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| AST | SELL | 2016-11-28 | $14K | — | Filing → |
| AST | SELL | 2016-11-21 | $13K | — | Filing → |
| AST | SELL | 2016-10-11 | $39K | — | Filing → |